Premd Inc (PREMF) 0.0001 $PREMF
Cardiac Marker Diagnostic Testing Markets 2015
M2 - Mon Feb 16, 5:25AM CST
Research and Markets (http://www.researchandmarkets.com/research/n3jhj5/cardiac_marker) has announced the addition of the "Cardiac Marker Diagnostic Testing Markets" report to their offering. Cardiac marker diagnostic testing measures the concentration of certain proteins, i.e., biomarkers, which indicate the presence or severity of cardiovascular disease (CVD). Among the most prevalent CVDs are sudden cardiac arrest (SCA), acute myocardial infarction (AMI), congestive heart failure (CHF) and atherosclerosis. Every year, an estimated 17 million people worldwide die from a CVD. This report describes the specific market segment of the in vitro diagnostics (IVD) market devoted to cardiac marker testing, including size; growth; industry trends; product development and investment; and clinical measurement devices, reagents and supplies. Highly-attractive cardiac marker areas of growth covered in this review include: the cardiac rapid assay market, troponins, Creatine kinase-myocardial band (CK-MB) and brain natriuretic peptide (BNP) testing. Also examined are heart failure, myoglobin, homocysteine (Hcy), C-reactive protein (CRP), pulmonary embolism (PE) (D-dimer test), low-density and high-density lipoproteins (LDL and HDL), stroke, cardiac enzymes, albumin, cardiac markers used in clinical decisions, cardiac markers in renal failure, cardiac panels and point of care (POC) cardiac markers. This study also provides a thorough analysis of the companies known to be marketing, manufacturing or developing cardiac marker products in the U.S. and worldwide, as well as detailed tables, charts and figures covering the U.S., Europe and Asia markets. Key Topics Covered: 1. Overview 2. The Basics of Biomarkers 3. Cardiac Marker Testing Markets: Market Segment Analysis: Size, Growth and Share 4. Cardiovascular Disease Markers 5. Cardiac Marker Testing Development Issues 6. Business Trends in the Industry 7. Important Technology Trends 8. Company Profiles - Abbott Laboratories and SWOT Analysis - Alere and SWOT Analysis - Beckman Coulter (now part of Danaher) - Biosite, Inc. (now a brand of Alere) - bioM?rieux - CardioGenics - Chek Diagnostics - diaDexus and SWOT Analysis - Health-Chem Diagnostics (HCD) - LifeSign, LLC - Ortho-Clinical Diagnostics, Inc. and SWOT Analysis - PTS Diagnostics - PreMD, Inc. - Radiometer Medical - Randox Laboratories Ltd. - Response Biomedical - Roche Diagnostics - Sanyo Chemical Industries Ltd. - Shionogi & Co., Ltd. - Siemens Healthcare Diagnostics - Sierra Resources International - Spectral Diagnostics, Inc. For more information visit http://www.researchandmarkets.com/research/n3...iac_marker
ABT: 40.12 (+0.68), DHR: 80.68 (+0.28)
MED-11 AG And Dr. Shamsuddin File Complaint In U.S. Federal Court Against PreMD Inc. Relating To Cancer Screening Tests And Kits
EWorldWire - Fri Oct 27, 12:20PM CDT
Swiss-based MED-11 AG and Dr. Abulkalam M. Shamsuddin have jointly filed a Complaint for Declaratory Judgment and Breach of Contract on October 19, 2006 against PreMD Inc. (TSX: PMD and Amex: PME) in the United States District Court for the District of Maryland.
Cardiac Marker Diagnostic Testing Markets 2015
M2 - Mon Feb 16, 5:25AM CST
Research and Markets (http://www.researchandmarkets.com/research/n3jhj5/cardiac_marker) has announced the addition of the "Cardiac Marker Diagnostic Testing Markets" report to their offering. Cardiac marker diagnostic testing measures the concentration of certain proteins, i.e., biomarkers, which indicate the presence or severity of cardiovascular disease (CVD). Among the most prevalent CVDs are sudden cardiac arrest (SCA), acute myocardial infarction (AMI), congestive heart failure (CHF) and atherosclerosis. Every year, an estimated 17 million people worldwide die from a CVD. This report describes the specific market segment of the in vitro diagnostics (IVD) market devoted to cardiac marker testing, including size; growth; industry trends; product development and investment; and clinical measurement devices, reagents and supplies. Highly-attractive cardiac marker areas of growth covered in this review include: the cardiac rapid assay market, troponins, Creatine kinase-myocardial band (CK-MB) and brain natriuretic peptide (BNP) testing. Also examined are heart failure, myoglobin, homocysteine (Hcy), C-reactive protein (CRP), pulmonary embolism (PE) (D-dimer test), low-density and high-density lipoproteins (LDL and HDL), stroke, cardiac enzymes, albumin, cardiac markers used in clinical decisions, cardiac markers in renal failure, cardiac panels and point of care (POC) cardiac markers. This study also provides a thorough analysis of the companies known to be marketing, manufacturing or developing cardiac marker products in the U.S. and worldwide, as well as detailed tables, charts and figures covering the U.S., Europe and Asia markets. Key Topics Covered: 1. Overview 2. The Basics of Biomarkers 3. Cardiac Marker Testing Markets: Market Segment Analysis: Size, Growth and Share 4. Cardiovascular Disease Markers 5. Cardiac Marker Testing Development Issues 6. Business Trends in the Industry 7. Important Technology Trends 8. Company Profiles - Abbott Laboratories and SWOT Analysis - Alere and SWOT Analysis - Beckman Coulter (now part of Danaher) - Biosite, Inc. (now a brand of Alere) - bioM?rieux - CardioGenics - Chek Diagnostics - diaDexus and SWOT Analysis - Health-Chem Diagnostics (HCD) - LifeSign, LLC - Ortho-Clinical Diagnostics, Inc. and SWOT Analysis - PTS Diagnostics - PreMD, Inc. - Radiometer Medical - Randox Laboratories Ltd. - Response Biomedical - Roche Diagnostics - Sanyo Chemical Industries Ltd. - Shionogi & Co., Ltd. - Siemens Healthcare Diagnostics - Sierra Resources International - Spectral Diagnostics, Inc. For more information visit http://www.researchandmarkets.com/research/n3...iac_marker
ABT: 40.12 (+0.68), DHR: 80.68 (+0.28)
MED-11 AG And Dr. Shamsuddin File Complaint In U.S. Federal Court Against PreMD Inc. Relating To Cancer Screening Tests And Kits
EWorldWire - Fri Oct 27, 12:20PM CDT
Swiss-based MED-11 AG and Dr. Abulkalam M. Shamsuddin have jointly filed a Complaint for Declaratory Judgment and Breach of Contract on October 19, 2006 against PreMD Inc. (TSX: PMD and Amex: PME) in the United States District Court for the District of Maryland.
